Reducing prescription drug costs for seniors: The ABCs of ASP for Part D
As we move into 2021, it is time to take stock of the myriad proposals related to making prescription drugs more affordable for patients. Both political...
Andrew Parece is a vice president in the Life Sciences Practice. With more than 30 years of consulting experience, Mr. Parece specializes in pricing and competitive strategy, quantitative analysis, modeling, and market research, primarily in the pharmaceutical, biotech, and life sciences industries. His work in pharmaceuticals has focused on pricing, contracting, market access, and brand/franchise strategy. He has managed competitive assessments and product launch strategy assignments for several high-profile products.
Mr. Parece served as a managing principal at Analysis Group from 2003 through 2014, leading its pricing strategy practice in its healthcare consulting group. From 1996–2002, he was a principal and vice president at CRA, consulting for healthcare and energy clients. Mr. Parece’s experience includes several years of consulting on market planning and analysis to electric and natural gas utilities and government. Mr. Parece speaks at professional conferences and writes on pharmaceuticals and life science topics for publications such as Pharmaceutical Executive.